rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Scott D. Kahn

Director

Company insider

Files Form 4 as: Director, Exagen.

In numbers

Trades disclosed
4
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
10 Jun 2024
Last trade
9 Jun 2026
Last filed
22 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
XGN ExagenDirector · Diagnostics & Labs · last 9 Jun 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
9 Jun 2026filed 22 Jun 2026XGN Exagenoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—37,500 at $0.00filing
9 Jun 2026filed 22 Jun 2026XGN Exagenoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—37,500 at $0.00filing
10 Jun 2025filed 12 Jun 2025XGN Exagenoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—9,000 at $0.00filing
10 Jun 2024filed 14 Jun 2024XGN Exagenoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—15,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Jeffrey G. BlackChief Financial Officer · Chief Financial Officer at Exagen, filing Form 4 there in the last year
Bruce C. RobertsonDirector · Director at Exagen, filing Form 4 there in the last year
Paul KimCFO and Treasurer · Director at Exagen, filing Form 4 there in the last year
Chas McKhannDirector · Director at Exagen, filing Form 4 there in the last year
Frank StokesChief Financial Officer · Director at Exagen, filing Form 4 there in the last year